All cancer types
Results
Phase 2
This trial looked at vemurafenib for cancers that have a specific change to a gene called BRAF. It was for people who had a number of different types of cancers including:
This trial was open to people to join between 2012 and 2015. These results were published in 2015.
Recruitment start: 1 July 2012
Recruitment end: 1 September 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Ian Chau
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 20 January 2020
CRUK internal database number: 9583